슬라이드 염색기 시장 : 제품, 방법, 용도 및 최종 사용자별 - 세계 예측(-2030년)

Slide Stainers Market Size, Share, Forecast, & Trends Analysis by Product (Reagent [Stains, Mounting, Processing] Equipment) Technique (H&E, ISH, IHC) Application (Diagnosis, Research), and End User (Hospital, Pharmaceutical, Academic)-Global Forecast to 2030

The global slide stainers market is projected to reach $5.53 billion by 2030 at a CAGR of 7.9% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. This growth is due to rising geriatric population, coupled with the growing burden of chronic diseases, technological advancements in slide stainers, increasing need for personalized treatment, rising healthcare expenditure, increasing demand for automation in diagnostics & clinical research, and increasing cancer drug research. However, the high cost of slide straining systems restrains the growth of this market.

Furthermore, the increasing demand for automated slide staining and diagnostic systems, along with growth opportunities in emerging economies, is expected to benefit players in this market. However, challenges such as concerns surrounding automated slide stainers, and a shortage of skilled professionals are impacting market growth significantly.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2023). The key players operating in the global slide stainers market are Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Abcam plc. (U.K.), Siemens Healthineers (Germany), General Data Company, Inc. (U.S.), Biocare Medical LLC (U.S.), BioGenex (U.S.), PHC Holdings Corporation (Japan), and Hardy Diagnostics (U.S.).

Among all the products studied in this report, in 2023, the reagents & kits segment is expected to account for the largest share of the slide stainers market. The growing emphasis on personalized medicine requires the use of highly specialized reagents such as special stains, cytology stains, mounting reagents, and others essential for diagnostic tests. It has resulted in the development of novel and creative slide-staining reagents, such as multiplex staining reagents, which enable the simultaneous detection of numerous biomarkers on a single slide, contributing to the large share of this segment.

Among all the techniques studied in this report, in 2023, the hematoxylin and eosin (H&E) segment is expected to account for the larger share of the slide stainers market. Technological advancements in hematoxylin and eosin staining are contributing to developing improved and automated staining methods. This has made H&E staining more accessible to healthcare professionals and academics, increasing its adoption, use, and acceptance. Furthermore, the growing demand for hematoxylin and eosin for laboratory uses, and diagnostic tests contributes to this segment's largest share.

Among all the end users studied in this report, in 2023, the hospitals & diagnostic centers segment is expected to account for the largest share of the slide stainers market. Slide stainers are significant in hospitals & diagnostic centers, particularly in pathology, histology, and laboratory medicine. Their use is essential for accurately diagnosing, and treating a wide range of medical conditions. Slide stainers are essential tools in hospitals & diagnostic centers, enabling accurate & efficient pathological assessments, aiding in disease diagnosis and staging, and contributing to research & education in the medical field. Their automation and standardization capabilities enhance the quality of patient care, and scientific discoveries.

An in-depth analysis of the geographical scenario of the global slide stainers market provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa), along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the slide stainers market. In 2023, the U.S. is expected to account for the largest share of the slide stainers market in North America. The large share of this regional market is attributed to the presence of major slide stainers companies such as Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), and Agilent Technologies, Inc. (U.S.). The increasing geriatric population, coupled with the growing burden of chronic diseases, technological advancements in slide stainers, increasing need for personalized treatments, rising healthcare expenditure policies in the region.

Scope of the Report:

Slide Stainers Market Assessment-by Product

• Reagents and Kits
  • Grossing/Tissue Marking Dyes
  • Tissue Fixation Reagents
  • Tissue Processing Reagents
  • Mounting/Embedding Reagents
  • Stains
• Hematoxylin and Eosin (H&E Stains)
• Cytology Stains
• Special Stains
• Stain Controls
  • Other Reagents and Kits
• Equipment
  • Automated slide Stainers
  • Manual Slide Stainers
• Accessories and Consumables

Note: Other reagents and kits include solvents, buffers, diluents, solutions, and tissue softeners.

Slide Stainers Market Assessment-by Technique

• Hematoxylin and Eosin (H&E)
• In-situ Hybridization (ISH)
• Microbiology
• Immunohistochemistry (IHC)
• Hematology
• Cytology

Slide Stainers Market Assessment-by Application

• Disease Diagnosis
  • Infectious Diseases
  • Cancer
  • Other Diseases
• Medical Research

Note: Other diseases include autoimmune diseases and hematological diseases.

Slide Stainers Market Assessment-by End Users

• Hospitals & Diagnostic Centers
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)

Slide Stainers Market Assessment-by Geography

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition and Scope
• 1.2. Market Ecosystem
• 1.3. Currency and Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection and Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
• 2.3. Market Sizing and Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Factors Affecting Market
  • 4.2.1. Drivers
    • 4.2.1.1. Rising Geriatric Population, Coupled with the Growing Burden of Chronic Diseases
    • 4.2.1.2. Technological Advancements in Slide Stainers
    • 4.2.1.3. Increasing Need for Personalized Treatment
    • 4.2.1.4. Rising Healthcare Expenditure
    • 4.2.1.5. Increasing Demand for Automation in Diagnostics and Clinical Research
    • 4.2.1.6. Increasing Cancer Drug Research
  • 4.2.2 Restraints
    • 4.2.2.1. High Cost of Slide Straining Systems
  • 4.2.3. Opportunities
    • 4.2.3.1. Emerging Economies
    • 4.2.3.2. Rising Demand for Automated Slide Staining and Diagnostic Systems
  • 4.2.4. Challenges
    • 4.2.4.1. Concerns Related to Automated Slide Stainers
    • 4.2.4.2. Lack of Skilled Professionals
  • 4.2.5. Factor Analysis
• 4.3. Regulatory Analysis
• 4.4. Pricing Analysis
• 4.5. Porter's Five Forces Analysis

5. Slide Stainers Market Size & Trend Analysis-by Product

• 5.1. Overview
• 5.2. Reagents and Kits
  • 5.2.1. Grossing/Tissue Marking Dyes
  • 5.2.2. Tissue Fixation Reagents
  • 5.2.3. Tissue Processing Reagents
  • 5.2.4. Mounting/Embedding Reagents
  • 5.2.5. Stains
    • 5.2.5.1. Hematoxylin and Eosin (H&E Stains)
    • 5.2.5.2. Cytology Stains
    • 5.2.5.3. Special Stains
    • 5.2.5.4. Stain Controls
  • 5.2.6. Other Reagents and Kits
• 5.3. Equipment
  • 5.3.1. Automated Slide Stainers
  • 5.3.2. Manual Slide Stainers
• 5.4. Accessories and Consumables

6. Slide Stainers Market Size & Trend Analysis-by Technique

• 6.1. Overview
• 6.2. Hematoxylin and Eosin (H&E)
• 6.3. In-situ Hybridization (ISH)
• 6.4. Microbiology
• 6.5. Immunohistochemistry (IHC)
• 6.6. Hematology
• 6.7. Cytology

7. Slide Stainers Market Size & Trend Analysis-by Application

• 7.1. Overview
• 7.2. Disease Diagnosis
  • 7.2.1. Infectious Diseases
  • 7.2.2. Cancer
  • 7.2.3. Other Diseases
• 7.3. Medical Research

8. Slide Stainers Market Size & Trend Analysis-by End User

• 8.1. Overview
• 8.2. Hospitals and Diagnostic Centers
• 8.3. Pharmaceutical and Biotechnology Companies
• 8.4. Academic and Research Institutes
• 8.5. Contract Research Organizations (CROs)

9. Slide Stainers Market Size & Trend Analysis-by Geography

• 9.1. Overview
• 9.2. North America
  • 9.2.1. U. S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. U.K.
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Rest of Europe
• 9.4. Asia-Pacific
  • 9.4.1. China
  • 9.4.2. Japan
  • 9.4.3. India
  • 9.4.4. Rest of Asia-Pacific
• 9.5. Latin America
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America
• 9.6. Middle East & Africa

10. Competition Analysis

• 10.1. Overview
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Competitive Dashboard
  • 10.4.1. Industry Leaders
  • 10.4.2. Market Differentiators
  • 10.4.3. Vanguards
  • 10.4.4. Emerging Companies
• 10.5. Market Share Analysis/Market Rankings (2022)

11. Company Overview (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)

• 11.1. Thermo Fisher Scientific (U.S.)
• 11.2. F. Hoffmann-La Roche AG (Switzerland)
• 11.3. Danaher Corporation (U.S.)
• 11.4. Merck KGaA (Germany)
• 11.5. Agilent Technologies, Inc. (U.S.)
• 11.6. Becton, Dickinson and Company (U.S.)
• 11.7. Abcam plc. (U.K.)
• 11.8. Siemens Healthineers (Germany)
• 11.9. General Data Company, Inc. (U.S.)
• 11.10. Biocare Medical, LLC. (U.S.)
• 11.11. BioGenex (U.S.)
• 11.12 PHC Holdings Corporation (Japan)
• 11.13. Hardy Diagnostics (U.S.)

(Note: SWOT analysis will be provided for only the top 5 companies.)

12. Appendix

• 12.1. Available Customization
• 12.2. Related Reports